在患有急性淋巴细胞白血病的儿童中,microRNA多态与甲索特酸诱导的毒性相关联
Vasiliki Karpa1, Kallirhoe Kalinderi1, Liana Fidani1
1Laboratory of Medical Biology-Genetics, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Hematology reports
|November 21, 2023
概括
微RNA变异可能会影响癌症患者的甲状腺素 (MTX) 毒性. 这项研究调查了这些遗传变异如何影响MTX的不良影响,从而有可能改善治疗个性化.
科学领域:
- 药物基因组学 药物基因组学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 甲甲酸 (MTX) 是治疗儿科急性淋巴细胞白血病 (ALL) 和其他癌症的重要化疗药物.
- 患者在MTX药理动力学/药理动力学上的变化会导致毒性和粘膜炎等不良事件.
- MTX运输基因中的遗传变异与毒性有关,之前的研究重点是单核酸多态 (SNP).
研究的目的:
- 调查微RNA (miRNA) 变体在调解甲状腺酸盐 (MTX) 副作用中的作用.
- 探索miRNA多态性对MTX药理学和毒性的影响.
主要方法:
- 关于miRNA多态性和MTX毒性的最新文献的综述.
- 对将miRNA调节与药物运输,新陈代谢和基因表达联系起来的研究进行分析.
- 专注于特定miRNA变体与MTX相关不良事件之间的关联.
主要成果:
- 新出现的证据强调了miRNAs在调节药物反应和毒性的重要作用.
- 米RNA多态性代表了对MTX不良影响的新研究领域.
- 研究表明miRNA变体与MTX诱导的毒性之间存在潜在联系.
结论:
- 密RNA变异是理解和预测MTX毒性的有希望领域.
- 对miRNA多态性的进一步研究可能会导致个性化的MTX剂量策略.
- 研究miRNA的作用可能有助于减轻不良事件并改善癌症治疗结果.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K


